Ascendis Pharma A/S (ASND) stock
ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$271.19−0.54 (-0.20%)
Close on Nov 17, 2026Market cap $16.81BP/E 22.3Yield –
Ascendis Pharma A/S price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
No price to book ratio figures for Ascendis Pharma A/S
Ascendis Pharma A/S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?